| pubmed-article:16268914 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:16268914 | lifeskim:mentions | umls-concept:C1800706 | lld:lifeskim |
| pubmed-article:16268914 | lifeskim:mentions | umls-concept:C0441655 | lld:lifeskim |
| pubmed-article:16268914 | lifeskim:mentions | umls-concept:C0333348 | lld:lifeskim |
| pubmed-article:16268914 | lifeskim:mentions | umls-concept:C1306673 | lld:lifeskim |
| pubmed-article:16268914 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:16268914 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:16268914 | pubmed:dateCreated | 2005-11-4 | lld:pubmed |
| pubmed-article:16268914 | pubmed:abstractText | The role of active inflammation in idiopathic pulmonary fibrosis (IPF) is controversial. A gallium-67 citrate (Ga(67) scan) is a sensitive indicator of inflammatory activity. The aim of this study was to assess the Ga(67) uptake and other markers of inflammation at different stages of IPF and to investigate its prognostic role. | lld:pubmed |
| pubmed-article:16268914 | pubmed:language | eng | lld:pubmed |
| pubmed-article:16268914 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:16268914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:16268914 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:16268914 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:16268914 | pubmed:issn | 1323-7799 | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:ZompatoriMaur... | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:ContiniPaolaP | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:FantiStefanoS | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:FasanoLucaL | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:MuraMarcoM | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:BelmonteGelor... | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:PacilliAngela... | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:SchiavinaMari... | lld:pubmed |
| pubmed-article:16268914 | pubmed:author | pubmed-author:FabbriMarioM | lld:pubmed |
| pubmed-article:16268914 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:16268914 | pubmed:volume | 10 | lld:pubmed |
| pubmed-article:16268914 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:16268914 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:16268914 | pubmed:pagination | 609-14 | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:meshHeading | pubmed-meshheading:16268914... | lld:pubmed |
| pubmed-article:16268914 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:16268914 | pubmed:articleTitle | Inflammatory activity is still present in the advanced stages of idiopathic pulmonary fibrosis. | lld:pubmed |
| pubmed-article:16268914 | pubmed:affiliation | UO Fisiopatologia Respiratoria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy. marcomura@hotmail.com | lld:pubmed |
| pubmed-article:16268914 | pubmed:publicationType | Journal Article | lld:pubmed |
